GlassScriptPhysician profile
Israel Rubinstein
NPI 1942305966
$107,088.41
in general payments reported to CMS, 2019-2025
10 companies · $9,433 in 2025
The $9,433 reported for 2025 was more than what 95% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75K · 2020: $18K · 2021: $2,686 · 2022: $1,936 · 2023: $107 · 2025: $9,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,450 · Travel and Lodging: $572 · Food and Beverage: $501 · Gift: $17.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,450.00 |
| Travel and Lodging | $571.58 |
| Food and Beverage | $501.27 |
| Gift | $17.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $82,034.89 | 2019-2021 | |
| Glaxosmithkline, LLC. | $9,433.34 | 2025 | Nucala |
| Sunovion Pharmaceuticals INC. | $5,063.10 | 2019 | |
| Insmed, INC. | $4,586.58 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $3,555.29 | 2019 | |
| Ge Healthcare | $1,686.00 | 2022 | |
| Advanced Respiratory, INC | $360.00 | 2021 | |
| Resmed Corp | $250.00 | 2022 | |
| Merck Sharp & Dohme LLC | $106.72 | 2023 | |
| Circassia INC. | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Israel Rubinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.